NASH AMPK Exercise Dosing (AMPED) Trial
Recruiting
N/A
Interventional Study
NAFLD
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 69
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 45 (estimated)
- Sponsor
- Milton S. Hershey Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
There is no known cure or regulatory agency approved drug therapy for nonalcoholic fatty liver disease (NAFLD), the leading cause of liver disease worldwide, and its progressive type, NASH. This places increased importance on using exercise to treat NAFLD.
While physical activity is recommended for all with NAFLD, how to best prescribe exercise as a specific treatment remains unknown, including w…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18-69 years
* Sedentary \[\<90 min/wk of exercise identified by the Get Active Questionnaire (GAQ)
* BMI \>25kg/m2
* Liver biopsy within six months prior to enrollment showing:
* NASH defined by NASH Clinical Research Network (CRN) histology scoring system (NAS) \>4 and…
Contacts